Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
23 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
107.5 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CHPC - SITE CHERBOURG
46 R DU VAL DE SAIRE BP 208, 50102 CHERBOURG OCTEVILLE CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Emerging infectious diseases · 2023
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2023
Purpose: The aim of this study is to report an Italian multicenter experience analyzing the incidence and the risk factors associated with spinal cord ischemia (SCI) in a large cohort of thoracoabdominal aortic aneurysms (TAAAs) treated by fenestrated-branched endovascular aneurysm repair (F-/B-EVAR). Materials and Methods: All consecutive patients undergoing F-/B-EVAR in 4 Italian university centers between 2008 and 2019 were prospectively recorded and retrospectively analyzed. Spinal cord ischemia, 30 day/in-hospital adverse events, and mortality were assessed as early outcomes. Risk factors for SCI were determined by multivariable analysis. Results: A total of 351 patients received F-/B-EVAR for a TAAA. Twenty-eight (8.0%) patients died within 30 postoperative days or during the hospitalization. Regarding SCI, 47 patients (13.4%) developed neurological symptoms related to spinal cord impaired perfusion. Among them, 17 (4.8%) had a major permanent impairment. The multivariable analysis identified that SCI was associated with Crawford extent I to III (odds ratio [OR]: 20.90, p=0.004, 95% confidence interval [CI]=2.69–162.57), and with endovascular procedures performed for ruptured TAAA (OR: 5.74, p=0.010, 95% CI=1.53–21.57). Spinal cord ischemia was also significantly associated with a grade 3 bleeding during the visceral stage (OR: 4.34, p=0.005, 95% CI=1.55–12.16) and a grade 2 renal insufficiency at 30 days (OR: 7.45, p=0.002, 95% CI=2.12–26.18). Conclusion: The present study indicates that SCI is still an open issue after extent I to III TAAA endovascular repair, while its incidence in extent IV TAAA and pararenal/juxtarenal aneurysms is rare. Thoracoabdominal aortic aneurysms extension, urgent TAAA repair for rupture, severe bleeding, and 30 day renal insufficiency have been identified as significant risk factors for SCI. In the presence of such factors, adjunctive strategies may be considered to reduce SCI rates, while in low-risk patients invasive or potentially-risky maneuvers might not be justified.
PLoS neglected tropical diseases · 2022
Rift Valley fever (RVF) is a zoonotic arbovirosis which has been reported across Africa including the northernmost edge, South West Indian Ocean islands, and the Arabian Peninsula. The virus is responsible for high abortion rates and mortality in young ruminants, with economic impacts in affected countries. To date, RVF epidemiological mechanisms are not fully understood, due to the multiplicity of implicated vertebrate hosts, vectors, and ecosystems. In this context, mathematical models are useful tools to develop our understanding of complex systems, and mechanistic models are particularly suited to data-scarce settings. Here, we performed a systematic review of mechanistic models studying RVF, to explore their diversity and their contribution to the understanding of this disease epidemiology. Researching Pubmed and Scopus databases (October 2021), we eventually selected 48 papers, presenting overall 49 different models with numerical application to RVF. We categorized models as theoretical, applied, or grey, depending on whether they represented a specific geographical context or not, and whether they relied on an extensive use of data. We discussed their contributions to the understanding of RVF epidemiology, and highlighted that theoretical and applied models are used differently yet meet common objectives. Through the examination of model features, we identified research questions left unexplored across scales, such as the role of animal mobility, as well as the relative contributions of host and vector species to transmission. Importantly, we noted a substantial lack of justification when choosing a functional form for the force of infection. Overall, we showed a great diversity in RVF models, leading to important progress in our comprehension of epidemiological mechanisms. To go further, data gaps must be filled, and modelers need to improve their code accessibility.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2025 · Journal Article
G A, C G, C J M, B L, et al.
Multiple sclerosis and related disorders · 2025 · Journal Article
Gerardo F, Bárbara E, Cecilia G, Aldana M, et al.
Journal of preventive medicine and hygiene · 2024 · Journal Article
Nicola V, Cecilia Q, Elisa F, Eleonora F, et al.
The Journal of clinical endocrinology and metabolism · 2024 · Letter
Cecilia P, Frederic C
Journal of electrocardiology · 2024 · Case Reports
Goffredo G, Correale M, Manfredi D, La Cecilia G, et al.
Emerging infectious diseases · 2023 · Journal Article
Arcari G, Cecilia F, Oliva A, Polani R, et al.
Annals of the rheumatic diseases · 2023 · Letter
C SK, Ahmed S, Shenoy V, Menon AR, et al.
Journal of clinical tuberculosis and other mycobacterial diseases · 2026 · Case Reports
Perugini E, Campogiani L, Coppola L, Cecilia F, et al.
Cureus · 2025 · Case Reports
C P, Ann Jose J, Verma G, Priya V L, et al.
Cureus · 2024 · Case Reports
Ramanan A, Balasubramanian V, C R, Sami P
JBJS case connector · 2024 · Case Reports
C A, Raju A, Meleppuram JJ, Nair AV, et al.
Pediatric blood & cancer · 2026 · Journal Article
Deana A, Gómez SM, Morán LE, Felice MS, et al.
European journal of pediatrics · 2024 · Journal Article
Yıldız Ç, Küçükali B, C SSB, Şenol PE, et al.
Children (Basel, Switzerland) · 2022 · Journal Article
Eldah TT, Mary M, Selina RN, Cecilia MT
Cureus · 2024 · Case Reports
Ramanan A, Balasubramanian V, C R, Sami P
PLoS neglected tropical diseases · 2022 · Systematic Review
Cecilia H, Drouin A, Métras R, Balenghien T, et al.
Cytokine · 2022 · Journal Article
Surboyo MDC, Boedi RM, Hariyani N, Santosh ABR, et al.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2023 · Multicenter Study
Rinaldi E, Melloni A, Gallitto E, Fargion A, et al.
Microorganisms · 2022 · Journal Article
Nicolò C, Federica T, De Nadai G, Sarah M, et al.
Advances in protein chemistry and structural biology · 2026 · Journal Article
Loganathan T, Madhulekha S, Zayed H, C GPD
Lupus · 2023 · Journal Article
Patil A, Shobha V, Shenoy P, S C, et al.
PLoS neglected tropical diseases · 2022 · Systematic Review
Cecilia H, Drouin A, Métras R, Balenghien T, et al.
Cytokine · 2022 · Journal Article
Surboyo MDC, Boedi RM, Hariyani N, Santosh ABR, et al.
European journal of pediatrics · 2024 · Journal Article
Yıldız Ç, Küçükali B, C SSB, Şenol PE, et al.
Scientific reports · 2025 · Journal Article
Antheia K, Eva F, Jan-Erik K, Henrik G, et al.
Cureus · 2025 · Case Reports
Lakshme I, C A, Senthil N, Pandurangan V
Cureus · 2026 · Case Reports
R S, Nanda M S, Adalarasan S, Subramanian Y, et al.